HopeStage
Back to all studies
Not recruitingISRCTN71929667

Two vs. one high-frequency rTMS session per day for treatment-resistant depression

Research studyAges 18–59Greece
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 59 years.

Listed locations
Greece

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
First Psychiatry Dept., Eginition Hospital, National and Kapodistrian University of Athens (Greece)
Sponsor type
University
Study type
Other
Intervention type
Other / unclear
Locations
Greece
Age range
From 18 Years to 59 Years
Official registry ID
ISRCTN71929667
Official title
Show the full official title

Two vs. one high-frequency rTMS session per day for treatment-resistant depression

Recruitment & locations

Not recruiting

Greece

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is First Psychiatry Dept., Eginition Hospital, National and Kapodistrian University of Athens (Greece), a university.

Who can participate?

Listed age limits: 18 years to 59 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies